Cart
sales@molnova.com
Pandacostat
CAS No. 1224158-00-2
Pandacostat( —— )
Catalog No. M10858 CAS No. 1224158-00-2
Pandacostat is the first nonselective HDAC inhibitor (pan-HDACi).
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePandacostat
-
NoteResearch use only, not for human use.
-
Brief DescriptionPandacostat is the first nonselective HDAC inhibitor (pan-HDACi).
-
DescriptionPandacostat is the first nonselective HDAC inhibitor (pan-HDACi) with Ki of 0.12/0.07/0.95/0.18/0.032/1.1/0.5/1.4 uM for HDAC1/2/3/4/5/6/7/8/9, respectively; exhibts activity in biochemical and cellular assay systems.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetHDAC
-
RecptorHDAC
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1224158-00-2
-
Formula Weight357.322
-
Molecular FormulaC17H15N3O6
-
Purity>98% (HPLC)
-
Solubility——
-
SMILES——
-
Chemical Name(E)-3-[4-[[[(E)-(2,3-dihydroxy-4-oxocyclohexa-2,5-dien-1-ylidene)methyl]amino]carbamoyl]phenyl]-N-hydroxyprop-2-enamide
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Bradner JE, et al. Nat Chem Biol. 2010 Mar;6(3):238-243.
molnova catalog
related products
-
Pyroxamide
Pyroxamide is an histone deacetylases (HDACs) inhibitor with antineoplastic properties ( HDAC1;IC50: 0.1-0.2 μM).
-
Vorinostat
A potent HDAC inhibitor, inhibits the activities of HDAC1 and HDAC3 with IC50 of 10 nM and 20 nM, respectively.
-
ACY-241
ACY-241, also known as Citarinostat, is a potent, selective and orally available histone deacetylase (HDAC) inhibitor, with potential antineoplastic activity.
